Study finds statin intolerance overestimated and overdiagnosed Fewer than 10% of patients prescribed cholesterol-lowering drugs experience side effects, according to the world’s largest study on statin intolerance.
HANDI site ‘more complete’ with new patient resources The new resources complement existing resources within HANDI and are aimed at helping GPs provide non-drug intervention-based care.
Why HANDI resource is underutilised Patients and doctors could both benefit from greater adoption of non-drug interventions, writes Professor Paul Glasziou.
Opioid treatment study ‘may impact’ future Australian guidelines Results from a clinical trial of extended-release buprenorphine injections reveal high retention and treatment satisfaction.
How can opioid deaths be reduced? New studies further verify the benefits of pharmacotherapy for opioid dependence in greatly reducing all-cause mortality rates.
Should GPs routinely prescribe naloxone to people who use opioids? Experts believe this measure may be life-saving, likening it to using an Epipen for anaphylaxis or intramuscular glucagon.
Wastewater reveals record high drug consumption New Australian data shows a spike in overall drug use at the height of the pandemic, but opioid use is down.
Overdose toll still worse than the road toll: report More than 2000 Australians died from drug overdoses in 2018, according to a report released on International Overdose Awareness Day.
Is there hidden trauma behind strict drug laws? Dr Hester Wilson raises concerns over the ‘drugs are bad’ mentality, when there is a proven harm-minimisation approach.
Top experts call for major new coalition on non-medical pandemic research The best successes against the ever-growing coronavirus pandemic have so far not come from drugs or vaccines, but from behavioural and social techniques.